Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Mixed Q3 Results
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total other income (expense): 77K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $159 thousand versus the consensus estimate of $180 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
